Table 2 Summary of existing pharmacological modulators that act directly or indirectly on endothelial activation-mediated leukocytes recruitment
Potential therapeutic | Formula | Targets | Mechanism of action | Refs |
|---|---|---|---|---|
Phellopterin | C17H16O5 | Akt, PKC | Reduce TNF-α-induced VCAM-1 expression and inhibits the adhesion of monocytes to endothelium | |
K-7174,K-7174 dihydrochloride | C33H48N2O6/C33H50Cl2N2O6 | GATA | Inhibit the expression of VCAM-1 induced by either IL-1β or TNF-α | |
Natalizumab | Monoclonal antibody | α4β1 integrin | A recombinant, humanized monoclonal antibody, binds to α4β1-integrin and blocks its interaction with VCAM-1 | |
Gypenoside XLIX | C52H86O21 | PPAR-α | A selective peroxisome proliferator-activated receptor (PPAR)-αactivator and inhibits cytokine-induced VCAM-1 overexpression | |
ICAM-1-IN-1 | C15H11BrN2O2S | Integrin | A potent and selective inhibitor of ICAM-1 | |
A-205804 | C15H12N2OS2 | ICAM-1, E-selectin | A potent and selective lead inhibitor of ICAM-1 and E-selectin | |
Lifitegrast (SAR 118) | C29H24Cl2N2O7S | LFA-1 | Inhibit T cell attachment to ICAM-1 | |
RWJ 50271 | C18H17F3N4O2S | LFA-1/ICAM-1 | A selective inhibitor of LFA-1/ICAM-1 | |
BMS-688521 | C26H19Cl2N5O4 | LFA-1/ICAM-1 | Inhibitor of the LFA-1/ICAM interaction | |
Bimosiamose (TBC-1269) | C46H54O16 | E-selectin/ P-selectin | A nonoligosaccharide pan-selectin antagonist | |
Andrographolide | C20H30O5 | NF-κB | Suppress the activation of NF-κB in stimulated endothelial cells | |
Sialyl-Lewis X | C31H52N2O23 | E-selectin | A high-affinity ligand for selectins and inhibits E-selectin-mediated neutrophil recruitment | |
PSI-697 | C21H18ClNO3 | P-selectin | Inhibit the binding of a soluble human P-selectin to PSGL-1 | |
Parmodulin 2 | C17H17BrN2O2 | PAR1 | An allosteric inhibitor of protease-activated receptor 1 (PAR1) |